FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

46843002: Xanthine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
78078018 Xanthine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
784236011 Xanthine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2699101000005112 Xanthin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xanthine Is a Puriner og derivater false Inferred relationship Some
Xanthine Is a Simple physiological organic compound false Inferred relationship Some
Xanthine Is a Intermediary product of metabolism true Inferred relationship Some
Xanthine Is a Allergen class false Inferred relationship Some
Xanthine Is a Vasodilator (substance) false Inferred relationship Some
Xanthine Is a Drug allergen false Inferred relationship Some
Xanthine Is a Drug pseudoallergen by function false Inferred relationship Some
Xanthine Is a Drug allergen false Inferred relationship Some
Xanthine Is a Xanthine or xanthine derivative false Inferred relationship Some
Xanthine Is a Xanthine and/or xanthine derivative (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Hypoxanthine Is a False Xanthine Inferred relationship Some
Xanthine measurement Has measured component False Xanthine Inferred relationship Some
Xanthine overdose Causative agent False Xanthine Inferred relationship Some
Aminophylline overdose Causative agent False Xanthine Inferred relationship Some
Accidental aminophylline overdose Causative agent False Xanthine Inferred relationship Some
Intentional aminophylline overdose Causative agent False Xanthine Inferred relationship Some
overdosis af aminophyllin, uvist med hvilken hensigt Causative agent False Xanthine Inferred relationship Some
Theophylline overdose Causative agent False Xanthine Inferred relationship Some
Accidental theophylline overdose Causative agent False Xanthine Inferred relationship Some
Intentional theophylline overdose Causative agent False Xanthine Inferred relationship Some
overdosis af theophyllin, uvist med hvilken hensigt Causative agent False Xanthine Inferred relationship Some
Xanthine measurement Component True Xanthine Inferred relationship Some 1
koffein og natriumbenzoat injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Xanthine adverse reaction Causative agent False Xanthine Inferred relationship Some
Aminophylline adverse reaction Causative agent False Xanthine Inferred relationship Some
Choline theophyllinate adverse reaction Causative agent False Xanthine Inferred relationship Some
Theophylline adverse reaction (disorder) Causative agent False Xanthine Inferred relationship Some
Allergy to xanthine Causative agent False Xanthine Inferred relationship Some
Allergy to aminophylline Causative agent False Xanthine Inferred relationship Some
allergi over for cholintheophyllinat Causative agent False Xanthine Inferred relationship Some
Allergy to theophylline (finding) Causative agent False Xanthine Inferred relationship Some
xanthinbronchodilatorer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing xanthine (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Xanthine Inferred relationship Some 1
caffein 5 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine citrate 20mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine + ergotamine tartrate 100mg/1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine + ergotamine tartrate 100mg/2mg suppository (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
guaifenesin 50 mg + oxtriphyllin 100 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
guaifenesin 50 mg + oxtriphyllin 100 mg eliksir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
guaifenesin + oxtriphyllin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + butalbital + caffein + codeinphosphat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
paracetamol + caffein + isometheptenmucat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine + ergotamine tartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine and sodium benzoate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing butalbital and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + orphenadrincitrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
paracetamol + butalbital + caffein + codeinphosphat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
oxtriphyllin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing aspirin and butalbital and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Xanthinol Is a False Xanthine Inferred relationship Some
Caffeine Is a False Xanthine Inferred relationship Some
Methyl xanthine Is a False Xanthine Inferred relationship Some
Uric acid Is a False Xanthine Inferred relationship Some
Diprophylline Is a False Xanthine Inferred relationship Some
Theobromine Is a False Xanthine Inferred relationship Some
Theophylline (substance) Is a False Xanthine Inferred relationship Some
Aminophylline (substance) Is a False Xanthine Inferred relationship Some
Dimenhydrinate (substance) Is a False Xanthine Inferred relationship Some
Pentoxifylline (substance) Is a False Xanthine Inferred relationship Some
xanthinbronchodilator Is a False Xanthine Inferred relationship Some
Aminophylline overdose Causative agent False Xanthine Inferred relationship Some
Accidental aminophylline overdose Causative agent False Xanthine Inferred relationship Some
Intentional aminophylline overdose Causative agent False Xanthine Inferred relationship Some
overdosis af aminophyllin, uvist med hvilken hensigt Causative agent False Xanthine Inferred relationship Some
Theophylline overdose Causative agent False Xanthine Inferred relationship Some
Accidental theophylline overdose Causative agent False Xanthine Inferred relationship Some
Intentional theophylline overdose Causative agent False Xanthine Inferred relationship Some
overdosis af theophyllin, uvist med hvilken hensigt Causative agent False Xanthine Inferred relationship Some
Aminophylline 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin 225 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin 350 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin 100 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin 25 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 10 mg/5 ml sukkerfri oral opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Theophylline 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 60 mg/5 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 175 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 250 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin kapsel med modificeret udløsning a 60 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin kapsel med modificeret udløsning a 125 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin kapsel med modificeret udløsning a 250 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 200 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 300 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 400 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some

Page 1 of 3 Next End


This concept is not in any reference sets

Back to Start